Cindy Hutnik

Prof. Cindy Hutnik

Ophthalmology, Western University, London, Ontario, Canada

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 January 2018 in PLOS ONE
Verified
Journal Article
Open access
PDF file
VKVinay Kansal
Vinay Kansal
JAJames J Armstrong
James J Armstrong
RPRobert Pintwala
Robert Pintwala
Cindy HutnikCindy Hutnik
Cindy Hutnik
Early detection, monitoring and understanding of changes in the retina are central to the diagnosis of glaucomatous optic neuropathy, and vital to reduce visual loss from this progressive condition. The main objective of this investigation was to compare glaucoma diagnostic accuracy of commercially available optical coherence tomography (OCT) devices (Zeiss Stratus, Zeiss Cirrus, Heidelberg Spectralis and Optovue RTVue, and Topcon 3D-OCT). 16,104 glaucomatous and 11,543 normal eyes reported in 150 studies. Between Jan. 2017 and Feb 2017, MEDLINE®, EMBASE®, CINAHL®, Cochrane Library®, Web of Science®, and BIOSIS® were searched for studies assessing glaucoma diagnostic accuracy of the aforementioned OCT devices. Meta-analysis was performed pooling area under the receiver operating characteristic curve (AUROC) estimates for all devices, stratified by OCT type (RNFL, macula), and area imaged. 150 studies with 16,104 glaucomatous and 11,543 normal control eyes were included. Key findings: AUROC of glaucoma diagnosis for RNFL average for all glaucoma patients was 0.897 (0.887–0.906, n = 16,782 patient eyes), for macula ganglion cell complex (GCC) was 0.885 (0.869–0.901, n = 4841 eyes), for macula ganglion cell inner plexiform layer (GCIPL) was 0.858 (0.835–0.880, n = 4211 eyes), and for total macular thickness was 0.795 (0.754–0.834, n = 1063 eyes). The classification capability was similar across all 5 OCT devices. More diagnostically favorable AUROCs were demonstrated in patients with increased glaucoma severity. Diagnostic accuracy of RNFL and segmented macular regions (GCIPL, GCC) scans were similar and higher than total macular thickness. This study provides a synthesis of contemporary evidence with features of robust inclusion criteria and large sample size. These findings may provide guidance to clinicians when navigating this rapidly evolving diagnostic area characterized by numerous options.

1 March 2011 in Clinical Ophthalmology
Verified
Journal Article
Open access
PDF file
TCToby Yb Chan
Toby Yb Chan
ARAmandeep S Rai
Amandeep S Rai
ELEdwin Lee
Edwin Lee
JGJordan T Glicksman
Jordan T Glicksman
Cindy HutnikCindy Hutnik
Cindy Hutnik
Background: This cross-sectional survey assessed the adequacy of ophthalmology teaching in undergraduate medical education and evaluated the comfort level of family medicine residents in diagnosing and managing common ophthalmic conditions. Methods: Postgraduate year 1 and 2 family medicine residents at the University of Western Ontario were recruited for this study. The main outcome measures were hours of classroom and clinic-based instruction on ophthalmology during undergraduate medical education, and the comfort level in ophthalmic clinical skills and managing various ophthalmic conditions. Results: In total, 54 (33.3%) of 162 family medicine residents responded to the survey. Residents reported an average of 27.1 ± 35.1 hours and 39.8 ± 47.1 hours of classroom and clinical ophthalmology instruction, respectively. However, most residents (80%) responded as feeling only "somewhat comfortable" or "not at all comfortable" in assessing and managing common ophthalmic conditions, including ocular emergencies, such as acute angle closure glaucoma and ocular chemical burn. A positive correlation was seen between overall comfort level and hours of classroom instruction (P < 0.05). Conclusion: The number of hours of ophthalmology training received by family medicine residents during medical school meets the International Council of Ophthalmology Task Force recommendations. However, family medicine residents appear to be uncomfortable in handling treatable but potentially sight-threatening ocular conditions. Standardizing the undergraduate medical education ophthalmology curriculum and increasing hours of ophthalmology training during postgraduate family medicine residency may be useful in bridging this gap in knowledge.

1 December 2010 in Clinical Ophthalmology
Verified
Journal Article
Open access
Cindy HutnikCindy Hutnik
Cindy Hutnik
CHCheema
Cheema
MMMohammad H Mohammad-Shahi
Mohammad H Mohammad-Shahi
Peer reviewed article authored by (Cindy Hutnik, Mohammad H Mohammad-Shahi). Read article or submit your manuscript for publishing.

1 September 1991 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
JSJoyce A. Sweeney
Joyce A. Sweeney
PHPaul A. Harmon
Paul A. Harmon
SASanford A. Asher
Sanford A. Asher
Cindy HutnikCindy Hutnik
Cindy Hutnik
ASArthur G. Szabo
Arthur G. Szabo

1 April 2017 in Clinical Ophthalmology
Verified
Journal Article
Open access
PDF file
YPYogesh Patodia
Yogesh Patodia
EGElizabeth Golesic
Elizabeth Golesic
AMAlex Mao
Alex Mao
Cindy HutnikCindy Hutnik
Cindy Hutnik
Purpose: The aim of this trial is to study the effectiveness of currently available low-vision devices in glaucoma patients with moderate-to-severe vision loss.
Design:
This is a randomized pilot clinical trial.
Participants:
Sixteen low-vision glaucoma patients participated in this study.
Methods:
Patients with a best-corrected visual acuity between 20/70 and 20/400 in the better eye and a diagnosis of stable primary or secondary open-angle glaucoma were randomized to a low-vision treatment group or a nonintervention control group. A telephone interview was conducted before and after the 4-week testing period to assess functional vision. Patients placed in the treatment group received a low-vision examination and used various currently available low-vision aids. Patients placed in the control group received a low-vision examination only. Changes in patients’ reading ability and overall visual ability were chosen as the primary outcomes. Other visual functioning domains (mobility, visual information processing and visual motor skills) were considered as secondary outcomes. Results: Ten patients in the treatment group showed a significant improvement in reading ability and overall visual ability compared to the control group. The difference in mean score for reading ability was 2.52 logits (2.02; P<0.05) and overall visual ability was 0.78 logits (0.64; P<0.05). However, no significant improvement was noted in the other visual functioning domains involving mobility and visual motor skills. Conclusion: Currently available low-vision devices primarily enhance central vision with limited benefits to functional activities relying on peripheral vision.

1 September 2012 in Clinical Ophthalmology
Verified
Journal Article
Open access
PDF file
Cindy HutnikCindy Hutnik
Cindy Hutnik
DKDov Kagan
Dov Kagan
HLHong Liu
Hong Liu
Background: Oxidative stress induced retinal pigment epithelium (RPE) dysfunction is hypothesized to be fundamental in the pathogenesis of age-related macular degeneration (AMD). This study investigated whether vitamin C, vitamin C phosphate, vitamin E, propofol, betaxolol, and N-acetyl cysteine (NAC) protect human RPE cells from oxidative stress. Methods: ARPE-19 cells were pretreated with the compounds under investigation. The chemical oxidant tert-butyl hydroperoxide (t-BOOH) was used to induce oxidative stress. Cell viability was determined using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Results: Exposure to t-BOOH resulted in a dose- and time-dependent reduction in ARPE-19 cell viability. Compared with cells given t-BOOH alone, vitamin E and NAC pretreated cells had significantly improved viability, propofol and betaxolol pretreated cells had no significant difference in viability, and vitamin C and vitamin C phosphate pretreated cells had significantly reduced viability. Conclusion: Of the compounds studied, only vitamin E and NAC significantly mitigated the effects of oxidative stress on RPE cells. Because of their potential therapeutic value for AMD patients, these and other RPE protective compounds continue to merit further investigation.